✦ LIBER ✦

Failure of Ganciclovir Prophylaxis of Primary Cytomegalovirus Disease in Immunologic High-Risk Recipients

✍ Scribed by D.J. Conti; A. Isenberg; G.K. Shen; A. Hahn; T.P. Singh

Book ID: 117236104
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 140 KB
Volume: 30
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(98)00256-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytomegalovirus Disease in High-Risk Tra

Cytomegalovirus Disease in High-Risk Transplant Recipients Despite Ganciclovir or Valganciclovir Prophylaxis

✍ Enver Akalin; Vinita Sehgal; Scott Ames; Sabera Hossain; Lisa Daly; Murphy Barba 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Oral ganciclovir versus valganciclovir f

Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients

✍ R.L. Brady; K. Green; C. Frei; P. Maxwell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Increased incidence of cytomegalovirus i

Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis

✍ Kevin T. Shiley; Leanne B. Gasink; Todd D. Barton; Patrice Pfeiffenberger; Kim M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Optimal measures for the prevention of cytomegalovirus (CMV) in high-risk orthotopic liver transplant (OLT) patients are unknown. The charts of high-risk OLT recipients with 12 months of follow-up who were transplanted over a 44-month period were reviewed. The incidence of CMV disease in CMV-seropos

Prevention of primary cytomegalovirus di

Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis

✍ R.H. Rubin; S.A. Kemmerly; D. Conti; M. Doran; B.M. Murray; J.F. Neylan; C. Papp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

A Randomized Prospective Trial of Oral V

A Randomized Prospective Trial of Oral Versus Intravenous Ganciclovir for Prophylaxis of Cytomegalovirus Infection and Disease in High-Risk Kidney Recipients

✍ M. Nafar; M. Lessan Pezeshki; F. Farrokhi; B. Einollahi; F. Pour-Reza-Gholi; A. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Prophylaxis of cytomegalovirus disease i

Prophylaxis of cytomegalovirus disease in high-risk patients

✍ M. Scholz; J. Cinatl; H. W. Doerr 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 813 KB